VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 113 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $168,000 | -33.1% | 35,712 | +1.8% | 0.07% | -31.7% |
| Q4 2020 | $251,000 | -7.4% | 35,079 | +38.0% | 0.10% | -26.8% |
| Q3 2020 | $271,000 | -25.5% | 25,411 | -12.0% | 0.14% | -17.4% |
| Q2 2020 | $364,000 | +49.2% | 28,874 | +8.1% | 0.17% | +72.0% |
| Q1 2020 | $244,000 | -42.9% | 26,708 | -12.7% | 0.10% | +42.9% |
| Q4 2019 | $427,000 | +137.2% | 30,608 | +193.5% | 0.07% | +94.4% |
| Q3 2019 | $180,000 | -40.0% | 10,430 | -5.3% | 0.04% | -42.9% |
| Q2 2019 | $300,000 | -38.9% | 11,011 | -57.1% | 0.06% | -94.0% |
| Q1 2019 | $491,000 | +78.5% | 25,651 | -12.2% | 1.04% | +2123.4% |
| Q4 2018 | $275,000 | -33.6% | 29,207 | +33.6% | 0.05% | +9.3% |
| Q3 2018 | $414,000 | -43.5% | 21,869 | -41.7% | 0.04% | -93.4% |
| Q2 2018 | $733,000 | -27.0% | 37,502 | -29.8% | 0.65% | -25.6% |
| Q1 2018 | $1,004,000 | +156.1% | 53,407 | +126.4% | 0.87% | +77.0% |
| Q4 2017 | $392,000 | – | 23,586 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |